Cargando…

A Longitudinal Follow-Up Study of Intellectual Function in Duchenne Muscular Dystrophy over Age: Is It Really Stable?

The aim of the study was to retrospectively evaluate the consistency of longitudinal findings on intellectual functioning in DMD boys and their relationship to behavioral and neuropsychiatric difficulties. The cohort included 70 patients of age 3 to 17 years with at least two assessments using the W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chieffo, Daniela P. R., Moriconi, Federica, Pane, Marika, Lucibello, Simona, Ferraroli, Elisabetta, Norcia, Giulia, Ricci, Martina, Capasso, Anna, Cicala, Gianpaolo, Buchignani, Bianca, Coratti, Giorgia, Cutrona, Costanza, Pelizzari, Monia, Brogna, Claudia, Hendriksen, Jos G. M., Muntoni, Francesco, Mercuri, Eugenio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865074/ https://www.ncbi.nlm.nih.gov/pubmed/36675332 http://dx.doi.org/10.3390/jcm12020403

Ejemplares similares

Language Development in Preschool Duchenne Muscular Dystrophy Boys
por: Chieffo, Daniela Pia Rosaria, et al.
Publicado: (2022)

Early Gross Motor Milestones in Duchenne Muscular Dystrophy
por: Norcia, Giulia, et al.
Publicado: (2021)

Detecting early signs in Duchenne muscular dystrophy: comprehensive review and diagnostic implications
por: Mercuri, Eugenio, et al.
Publicado: (2023)

Longitudinal Motor Functional Outcomes and Magnetic Resonance Imaging Patterns of Muscle Involvement in Upper Limbs in Duchenne Muscular Dystrophy
por: Brogna, Claudia, et al.
Publicado: (2021)

Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment?
por: Vicari, Stefano, et al.
Publicado: (2018)

Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study
por: Chieffo, Daniela, et al.
Publicado: (2015)

Functional levels and MRI patterns of muscle involvement in upper limbs in Duchenne muscular dystrophy
por: Brogna, Claudia, et al.
Publicado: (2018)

Muscle-MRI and Functional Levels for the Evaluation of Upper Limbs in Duchenne Muscular Dystrophy: A Critical Review of the Literature
por: Cristiano, Lara, et al.
Publicado: (2022)

Respiratory function and therapeutic expectations in DMD: families experience and perspective
por: Brogna, Claudia, et al.
Publicado: (2020)

Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy
por: Coratti, Giorgia, et al.
Publicado: (2022)

Sleep Disorders in Autism Spectrum Disorder Pre-School Children: An Evaluation Using the Sleep Disturbance Scale for Children
por: Romeo, Domenico M., et al.
Publicado: (2021)

Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?
por: Pane, Marika, et al.
Publicado: (2023)

The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials
por: Ricotti, Valeria, et al.
Publicado: (2016)

Assessing floppy infants: a new module
por: Cutrona, Costanza, et al.
Publicado: (2022)

Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis
por: Coratti, Giorgia, et al.
Publicado: (2021)

Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module
por: Berti, Beatrice, et al.
Publicado: (2021)

Revised North Star Ambulatory Assessment for Young Boys with Duchenne Muscular Dystrophy
por: Mercuri, Eugenio, et al.
Publicado: (2016)

Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening
por: Pane, Marika, et al.
Publicado: (2022)

Pediatric Motor Inflammatory Neuropathy: The Role of Antiphospholipid Antibodies
por: Brogna, Claudia, et al.
Publicado: (2020)

Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
por: Brogna, Claudia, et al.
Publicado: (2019)

Longitudinal natural history of type I spinal muscular atrophy: a critical review
por: Mercuri, Eugenio, et al.
Publicado: (2020)

Letter to the Editor: In response to P.R. Clemens et al., Efficacy and Safety of Viltolarsen in Boys with Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study, and Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
por: Muntoni, Francesco, et al.
Publicado: (2023)

North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up
por: Coratti, Giorgia, et al.
Publicado: (2021)

Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53
por: Brogna, Claudia, et al.
Publicado: (2019)

Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data
por: Pane, Marika, et al.
Publicado: (2018)

Cortical Thickness and Clinical Findings in Prescholar Children With Autism Spectrum Disorder
por: Lucibello, Simona, et al.
Publicado: (2022)

Specific Learning Disorders (SLD) and Behavior Impairment: Comorbidity or Specific Profile?
por: Chieffo, Daniela Pia Rosaria, et al.
Publicado: (2023)

Diagnostic journey in Spinal Muscular Atrophy: Is it still an odyssey?
por: Pera, Maria Carmela, et al.
Publicado: (2020)

Body mass index in type 2 spinal muscular atrophy: a longitudinal study
por: Ferrantini, Gloria, et al.
Publicado: (2022)

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
por: Frank, Diane E., et al.
Publicado: (2020)

Development of Exon Skipping Therapies for Duchenne Muscular Dystrophy: A Critical Review and a Perspective on the Outstanding Issues
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2017)

Nusinersen efficacy data for 24‐month in type 2 and 3 spinal muscular atrophy
por: Pane, Marika, et al.
Publicado: (2022)

Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy
por: Pera, Maria C., et al.
Publicado: (2017)

Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study
por: Pera, Maria Carmela, et al.
Publicado: (2023)

Duchenne muscular dystrophy in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact
por: Orso, Massimiliano, et al.
Publicado: (2023)

Gene therapy in Duchenne muscular dystrophy: Identifying and preparing for the challenges ahead
por: Heslop, Emma, et al.
Publicado: (2021)

Timed Rise from Floor as a Predictor of Disease Progression in Duchenne Muscular Dystrophy: An Observational Study
por: Mazzone, Elena S., et al.
Publicado: (2016)

Genetic modifiers of upper limb function in Duchenne muscular dystrophy
por: Sabbatini, Daniele, et al.
Publicado: (2022)

The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy
por: Scaglioni, Dominic, et al.
Publicado: (2021)

Development of a novel startle response task in Duchenne muscular dystrophy
por: Maresh, Kate, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ci5n07j32movmcddlnis16bb9v